Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Probable tRNA methyltransferase 9B (TRMT9B) is an enzyme and member of the tRNA methyltransferase family, closely related to yeast tRNA methyltransferase 9 (Trm9). TRMT9B retains the sequence and structural elements of a methyltransferase but is not required for global tRNA wobble uridine methylation, unlike its paralog ALKBH8[1][3]. TRMT9B is especially enriched in the nervous system and functions postsynaptically to regulate synaptic growth and promote neurotransmitter release, contributing to nervous system development[3][1][2]. In animal models, loss of TRMT9B leads to defects in synaptogenesis that are dependent on its methyltransferase activity. TRMT9B has also been studied for its potential tumor suppressor properties, but its physiological substrate and therapeutic targeting remain unclear[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Probable tRNA methyltransferase 9B (TRMT9B).